Cantargia Presented Positive Phase I Clinical Data with Lead Candidate CAN04 at ESMO - Seite 3

Cantargia is listed on Nasdaq Stockholm (ticker: CANTA). More information about Cantargia is available at http://www.cantargia.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/cantargia-ab/r/cantargia-presented-positive-phase-i-clinical-data-with-lead-candidate-can04-at-esmo,c2650084

The following files are available for download:

http://mb.cision.com/Main/7470/2650084/929948.pdf

PDF

For further information, please contact
Göran Forsberg, CEO
Telephone: [phone]
E-mail: [e-mail]